14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Signals

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 108 days ( 0 % )
Last Price $0.0536 0 %
High/ Low $0.0536 - $0.0536 0%
Chg 7 Days N/A $0.0536 $0.0536
Chg 30 Days N/A $0.0536 $0.0536
Chg 12 mos -33.06 % $0.0800 $0.0536
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -25.07 % Width: 109.24 %
Pred. range - 3 mos $0.0536 - $0.0536 0 % - 0 %
Pred. range - 12 mos $0.0219 - $0.0458 -59.15 % - -14.52 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Oct 25, 2019 - 118 days
Long MA avg 12 mos Sell Feb 13, 2020 - 43 days
Short/Long MA avg 12 mos Sell Feb 13, 2020 - 43 days
Pivot Short Sell Apr 14, 2020 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT